Venture Capital

With $2M in new funding, Fermeate is using light to supercharge microbes, promising to slash costs and boost output in the precision fermentation industry.

A new game backed by science aims to improve youth well-being and inspire water stewardship. But can this 'conscious play' model build a real movement?

A new partnership brings sustainable, wash-free lab tech to the GCC & MENA, aiming to accelerate drug discovery in the world's fastest-growing life-science market.

With $6M in new funding and a $60M valuation, influencer-founded Neutonic is taking its nootropic drinks from podcast fame to global supermarket shelves.

AI Council 2026 reveals the industry's next chapter: European founders are flocking to SF, engineering is being reinvented, and video is set to break everything.

Backed by $37M and Hims & Hers co-founder Jack Abraham, Golden Child is challenging the fresh pet food market with a new science-backed food system.

A new AI video solution from V4b.AI promises to solve generative AI's accuracy problem, offering brands a scalable, shoot-free alternative for content.

Amid rising demand for flexible stays, Landing hires key leaders in finance and partnerships to accelerate its national expansion and solidify its market position.

A new cell-free therapy, Ultrasome™, shows a 93% response rate in a pilot study, offering a scalable, regenerative solution for millions with knee pain.

Now trading as EFOR, the tech giant launches a unified identity to drive growth, but faces questions after a challenging first-quarter financial report.

Vensica Medical gets FDA clearance for a Phase 2 study of its ultrasound device that delivers botulinum toxin without needles for overactive bladder.

As GPS jamming becomes a critical threat, Northrop Grumman's new EGI-M system, powered by Green Hills software, ensures US jets stay on target.

The firm's unique chip design, integrating lasers on silicon, aims to solve the data bottleneck crippling AI and secures major deep tech investor backing.

With its Q1 2026 results imminent, the parent of Betway and Spin faces scrutiny to see if its global strategy can uphold its stellar financial momentum.

An $850M deal for an Arizona cobalt plant marks a pivotal US-Japan move to secure supply chains for defense, EVs, and advanced tech from rivals.

ThreatDown, the business-focused unit from Malwarebytes, has radically transformed its sales model, betting its future on a partner-first strategy.

With a massive Series A, Coultreon Biopharma is advancing a novel SIK3 inhibitor spun out of Galapagos to rival injectable blockbusters for autoimmune disease.

A new report shows 50% of founders fear AI disruption, while burnout and the timeless challenge of product-market fit continue to plague the startup world.

Alumnus Giuseppe Racanelli's landmark donation will rename a building and fund entrepreneurship, research, and crucial student mental health support.

Summation's new 'Reports' feature promises to deliver verified, repeatable AI analysis, tackling the critical problem of trust in corporate decision-making.